Jakarta, October 1, 2025 – PT Pyridam Farma Tbk (PYFA) is proud to announce its achievement in winning the Indonesia Most Reputable Company Champion 2025 award with a “Very Good” predicate. This achievement was secured, in part, through the superior performance of PYFA’s Corporate Communication division at the awards event organized by SWA and Business Digest on September 23 at the Shangri-La Hotel, Jakarta.
Indonesia Most Reputable Company Champion 2025 is part of the SWA-Business Digest Champion Awarding (SBCA) program, an awards event held for companies judged successful in creating innovations, programs, and superior performance in supporting long-term business sustainability and growth.
In the Indonesia Most Reputable Company Champions 2025 category, PYFA’s Corporate Communication division achieved the “Very Good” predicate while competing alongside several other prestigious companies such as Astra International Tbk, PT Global Digital Niaga (Blibli), HM Sampoerna Tbk, Baznas RI, PT Daya Anugrah Mandiri (Daya Motor), and PT Sinar Digital Terdepan (Xendit).
Kemal Gani, Chairman of SWA, stated, “The Indonesia Most Reputable Company Champion award is given to companies that successfully maintain consistent reputation through real programs and initiatives. PYFA is one of the companies capable of showing a strong commitment to continuous growth while maintaining public trust. This is worthy of appreciation because a good reputation is the foundation for long-term business sustainability.”
PYFA earned this award through a selection process that assessed company performance throughout 2024 until mid-2025. The evaluation covered various programs and initiatives run by PYFA to maintain and strengthen its reputation as an Indonesian pharmaceutical company that consistently innovates and contributes to society.
PYFA Corporate Communication Manager, Leilanie Nadia Kusuma, added, “We are deeply honored to receive the Indonesia Most Reputable Company Champion 2025 award. This success is certainly inseparable from the hard work and dedication of the PYFA Corporate Communication team, which has delivered strategic programs and initiatives to maintain and strengthen the company’s reputation. More than just an award, this achievement serves as momentum for us to strengthen investor and public trust, as well as affirm PYFA’s position as a global-standard Indonesian pharmaceutical company.”
Furthermore, the PYFA Corporate Communication team was also entrusted to lead a conference session during the awarding ceremony, discussing strategies for building brand trust and brand reputation in the current era. This opportunity further emphasizes PYFA’s role as a company that not only maintains internal reputation but also serves as a role model in effective corporate communication practices in Indonesia.
With this achievement, PYFA further reinforces its commitment to prioritizing transparency, excellence, and sustainability in every business step. Moving forward, PYFA will continue to present strategic initiatives to support company growth while providing added value for stakeholders, including investors, partners, and the wider community.
About Pyfa
PT Pyridam Farma Tbk, known under the brand PYFA, is a public pharmaceutical company listed on the Indonesia Stock Exchange (Ticker: PYFA). PYFA operates several business units producing prescription medicines in various forms, including tablets, capsules, creams, and injections. PYFA also has several well-known subsidiaries, including PT Holi Pharma, PT Ethica Industri Farmasi, and Probiotec Multipack.
Media Relations
Leilanie Nadia Kusuma
Head of Corporate Communications
Website : www.pyfa.co.id
Email : corcomm@pyfa.co.id
